Lisata Therapeutics (FRA:8NE) Float Percentage Of Total Shares Outstanding: 82.64% (As of Jul. 10, 2026)


FRA:8NE Lisata Therapeutics Inc FRA:8NE
32 GF Score
Price €2.74
! 4 Warning Signs
View Full Analysis

What is Lisata Therapeutics Float Percentage Of Total Shares Outstanding?

Lisata Therapeutics FRA:8NE -1.44% 32 Float Percentage Of Total Shares Outstanding is 82.64% as of Jul. 10, 2026. GuruFocus rates FRA:8NE with a GF Score™ of 32/100. The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lisata Therapeutics's float shares is 7.53 Mil. Lisata Therapeutics's total shares outstanding is 9.11 Mil. Lisata Therapeutics's float percentage of total shares outstanding is 82.64%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lisata Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lisata Therapeutics's Institutional Ownership is 4.88%.

FRA:8NE
32GF Score
Lisata Therapeutics Inc FRA:8NE
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lisata Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Lisata Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=7.53/9.11
=82.64%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 82.64% mean?
Lisata Therapeutics (FRA:8NE) has a Float Percentage Of Total Shares Outstanding of 82.64% as of Jul. 10, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Lisata Therapeutics and its competitors.
Is Lisata Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Lisata Therapeutics' current Float Percentage Of Total Shares Outstanding is 82.64%. Overall, Lisata Therapeutics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Lisata Therapeutics' Float Percentage Of Total Shares Outstanding compare to SGMO and NNVC?
Lisata Therapeutics' Float Percentage Of Total Shares Outstanding of 82.64% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Lisata Therapeutics and its competitors. Lisata Therapeutics's current Float Percentage Of Total Shares Outstanding is 82.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lisata Therapeutics stock overvalued right now?
Lisata Therapeutics (FRA:8NE) has a current Float Percentage Of Total Shares Outstanding of 82.64%. The current Float Percentage Of Total Shares Outstanding is 82.64%. Lisata Therapeutics' overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Lisata Therapeutics (FRA:8NE), the current Float Percentage Of Total Shares Outstanding is 82.64% as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lisata Therapeutics Business Description

Other Exchanges LSTA:USA0HS8:UK
Address 110 Allen Road, 2nd Floor, Basking Ridge, NJ, USA, 07920
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
32GF Score

Get the complete analysis for FRA:8NE

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.74
Price